2024
A case report on symptomatic disease caused by serotype 4 vaccine virus following tetravalent anti-dengue vaccination
Oliveira R, Santos A, Gonçalves C, Giovanetti M, Alcantara L, Demarchi L, Lichs G, Ilis T, Hiane S, Abbud A, Sacchi C, Naveca F, Santos D, Marques E, Lucena Junior W, Croda J. A case report on symptomatic disease caused by serotype 4 vaccine virus following tetravalent anti-dengue vaccination. Travel Medicine And Infectious Disease 2024, 62: 102782. PMID: 39461453, DOI: 10.1016/j.tmaid.2024.102782.Peer-Reviewed Original Research
2022
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
Ranzani OT, Hitchings MDT, de Melo RL, de França GVA, Fernandes CFR, Lind ML, Torres MSS, Tsuha DH, David LCS, Said RFC, Almiron M, de Oliveira RD, Cummings DAT, Dean NE, Andrews JR, Ko AI, Croda J. Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil. Nature Communications 2022, 13: 5536. PMID: 36202800, PMCID: PMC9537178, DOI: 10.1038/s41467-022-33169-0.Peer-Reviewed Original Research